{"id":"iberet-folic-500","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset (nausea, constipation, abdominal discomfort)"},{"rate":null,"effect":"Dark stools"},{"rate":null,"effect":"Metallic taste"}]},"_chembl":{"chemblId":"CHEMBL1622","moleculeType":"Small molecule","molecularWeight":"441.40"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The drug provides ferrous iron to replenish depleted iron stores and restore hemoglobin synthesis, while folic acid (vitamin B9) supports red blood cell formation and DNA synthesis. Together, these micronutrients address the dual deficiencies commonly seen in nutritional anemias, particularly in pregnancy and in populations with inadequate dietary intake.","oneSentence":"Iberet-Folic-500 is a hematinc supplement combining iron and folic acid to treat and prevent nutritional anemia and folate deficiency.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:47:49.593Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Iron deficiency anemia"},{"name":"Folic acid deficiency"},{"name":"Anemia in pregnancy"},{"name":"Nutritional anemia prevention and treatment"}]},"trialDetails":[{"nctId":"NCT04505514","phase":"PHASE4","title":"Single Dose Intravenous Iron Isomaltoside in Combination With Oral Iron vs Oral Iron Monotherapy in Patients With Anemia After Postpartum Haemorrhage","status":"UNKNOWN","sponsor":"University of Malaya","startDate":"2020-08-01","conditions":"Post Partum Hemorrhage, Anemia","enrollment":60}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"BLADDER DISTENSION"},{"count":1,"reaction":"BLOOD GLUCOSE INCREASED"},{"count":1,"reaction":"BLOOD URINE"},{"count":1,"reaction":"CEREBROVASCULAR ACCIDENT"},{"count":1,"reaction":"NAUSEA"},{"count":1,"reaction":"PROSTATE EXAMINATION ABNORMAL"},{"count":1,"reaction":"RENAL FAILURE ACUTE"},{"count":1,"reaction":"SUSPECTED COUNTERFEIT PRODUCT"},{"count":1,"reaction":"VOMITING"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Iberet-Folic-500","genericName":"Iberet-Folic-500","companyName":"University of Malaya","companyId":"university-of-malaya","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Iberet-Folic-500 is a hematinc supplement combining iron and folic acid to treat and prevent nutritional anemia and folate deficiency. Used for Iron deficiency anemia, Folic acid deficiency, Anemia in pregnancy.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}